keyword
MENU ▼
Read by QxMD icon Read
search

ovarian biomarkers

keyword
https://www.readbyqxmd.com/read/29026339/possibility-of-using-superoxide-dismutase-and-glutathione-peroxidase-as-endometriosis-biomarkers
#1
Sophapun Ekarattanawong, Chamnan Tanprasertkul, Charintip Somprasit, Pholasit Chamod, Rattana Tiengtip, Kornkarn Bhamarapravatana, Komsun Suwannarurk
OBJECTIVE: To study the possibility of using superoxide dismutase (SOD) and glutathione peroxidase (GPx) as combined preoperative biomarkers for endometriosis. PARTICIPANTS AND METHODS: Female patients aged between 18 and 45 years old who came to the Gynecology outpatient clinic, Thammasat University Hospital, during September 2013-2016 with the complaint of gynecologic symptoms suspected of endometriosis, and who were positively diagnosed with endometriosis, were included in this study...
2017: International Journal of Women's Health
https://www.readbyqxmd.com/read/29020678/ovarian-cancer-a-heterogeneous-disease
#2
Myriam Kossaï, Alexandra Leary, Jean-Yves Scoazec, Catherine Genestie
Ovarian cancer encompasses a collection of neoplasms with distinct clinicopathological and molecular features and prognosis. Despite there being a variety of ovarian cancer subtypes, these are treated as a single disease. Tremendous efforts have been made to characterize these subtypes and identify tumoral pathways and potential biomarkers for therapeutic strategies. As in other cancer types, tumor heterogeneity appears to be very high across subtypes and within a single tumor, representing a major cause of treatment failure...
October 12, 2017: Pathobiology: Journal of Immunopathology, Molecular and Cellular Biology
https://www.readbyqxmd.com/read/29020239/reproductive-aging-and-hepatic-fibrosis-progression-in-hiv-hepatitis-c-virus-co-infected-women
#3
Monika Sarkar, Jennifer L Dodge, Ruth M Greenblatt, Mark H Kuniholm, Jack DeHovitz, Michael Plankey, Andrea Kovacs, Audrey L French, Eric C Seaberg, Igho Ofotokun, Margaret Fischl, Edgar Overton, Erin Kelly, Peter Bacchetti, Marion G Peters
Background: Severity of hepatic fibrosis is greater in post- as compared to pre-menopausal women, perhaps due to protective effects of estrogens. However, prior studies of estrogen and liver fibrosis lack serial fibrosis measures, adjustment for age, or longitudinal observations in co-infected populations. Methods: In a longitudinal cohort of HIV/HCV co-infected women we assessed fibrosis progression across reproductive age using validated serum fibrosis markers, APRI and FIB-4...
July 26, 2017: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/29019869/the-analysis-of-cell-cycle-related-proteins-in-ovarian-clear-cell-carcinoma-versus-high-grade-serous-carcinoma
#4
Yukiko Hazama, Takuya Moriya, Mika Sugihara, Rikiya Sano, Mitsuru Shiota, Takafumi Nakamura, Koichiro Shimoya
In Japan, the frequency of ovarian clear cell carcinoma (CCC) is twice as high as that in the United States and Europe. Often, patient prognosis of CCC is poor because of chemoresistance. Here, we focus on the cell cycle, which is one of the mechanisms of chemoresistance. To detect the informative markers and improve the strategy of chemotherapy for CCC, we performed immunochemical staining of cell cycle-related proteins in ovarian malignant tumors. We detected that each of the 29 samples of CCC and high-grade serous carcinoma (HGSC) were necessary to reveal the significant differences in immunostaining and prognosis...
October 10, 2017: International Journal of Gynecological Pathology
https://www.readbyqxmd.com/read/29017919/whole-cell-biopanning-with-a-synthetic-phage-display-library-of-nanobodies-enabled-the-recovery-of-follicle-stimulating-hormone-receptor-inhibitors
#5
Ronan Crepin, Gianluca Veggiani, Selma Djender, Anne Beugnet, François Planeix, Christophe Pichon, Sandrine Moutel, Sebastian Amigorena, Franck Perez, Nicolae Ghinea, Ario de Marco
Antibodies are essential reagents that are increasingly used in diagnostics and therapy. Their specificity and capacity to recognize their native antigen are critical characteristics for their in vivo application. Follicle-stimulating hormone receptor is a GPCR protein regulating ovarian follicular maturation and spermatogenesis. Recently, its potentiality as a cancer biomarker has been demonstrated but no antibody suitable for in vivo tumor targeting and treatment has been characterized so far. In this paper we describe the first successful attempt to recover recombinant antibodies against the FSHR and that: i) are directly panned from a pre-immune library using whole cells expressing the target receptor at their surface; ii) show inhibitory activity towards the FSH-induced cAMP accumulation; iii) do not share the same epitope with the natural binder FSH; iv) can be produced inexpensively as mono- or bivalent functional molecules in the bacterial cytoplasm...
October 7, 2017: Biochemical and Biophysical Research Communications
https://www.readbyqxmd.com/read/28985654/environmental-pollution-affects-molecular-and-biochemical-responses-during-gonadal-maturation-of-astyanax-fasciatus-teleostei-characiformes-characidae
#6
REVIEW
Carlos E Tolussi, Aline D Olio Gomes, Anupama Kumar, Cristiele S Ribeiro, Fabiana L Lo Nostro, Peter A Bain, Gabriela B de Souza, Rodrigo Da Cuña, Renato M Honji, Renata G Moreira
Endocrine disrupting compounds (EDCs) have the potential to alter fish reproduction at various levels of organization. The aim of this study was to assess the impact of a natural environment with heavily anthropogenic influence on the physiological processes involved in reproduction in the freshwater fish lambari (Astyanax fasciatus) using different biomarkers. Adult males and females were collected in different seasons from two distinct sites in the same watershed: Ponte Nova Reservoir (PN) considered a pristine or small anthropogenic influence reference point; and Billings Reservoir (Bil), subjected to a large anthropogenic impact...
October 2, 2017: Ecotoxicology and Environmental Safety
https://www.readbyqxmd.com/read/28984489/directing-the-use-of-ddr-kinase-inhibitors-in-cancer-treatment
#7
Inger Brandsma, Emmy D G Fleuren, Chris T Williamson, Christopher J Lord
Introduction Defects in the DNA damage response (DDR) drive the development of cancer by fostering DNA mutation but also provide cancer-specific vulnerabilities that can be exploited therapeutically. The recent approval of three different PARP inhibitors for the treatment of ovarian cancer provides the impetus for further developing targeted inhibitors of many of the kinases involved in the DDR, including inhibitors of ATR, ATM, CHEK1, CHEK2, DNAPK and WEE1. Areas covered We summarise the current stage of development of these novel DDR kinase inhibitors, and describe which predictive biomarkers might be exploited to direct their clinical use...
October 6, 2017: Expert Opinion on Investigational Drugs
https://www.readbyqxmd.com/read/28984201/identification-of-common-oncogenic-and-early-developmental-pathways-in-the-ovarian-carcinomas-controlling-by-distinct-prognostically-significant-microrna-subsets
#8
Vladimir A Kuznetsov, Zhiqun Tang, Anna V Ivshina
BACKGROUND: High-grade serous ovarian carcinoma (HG-SOC) is the dominant tumor histologic type in epithelial ovarian cancers, exhibiting highly aberrant microRNA expression profiles and diverse pathways that collectively determine the disease aggressiveness and clinical outcomes. However, the functional relationships between microRNAs, the common pathways controlled by the microRNAs and their prognostic and therapeutic significance remain poorly understood. METHODS: We investigated the gene expression patterns of microRNAs in the tumors of 582 HG-SOC patients to identify prognosis signatures and pathways controlled by tumor miRNAs...
October 3, 2017: BMC Genomics
https://www.readbyqxmd.com/read/28978006/mitochondrial-mrna-transcripts-predict-overall-survival-tumor-recurrence-and-progression-in-serous-ovarian-cancer-companion-diagnostics-for-cancer-therapy
#9
Federica Sotgia, Michael P Lisanti
Here, we performed a systematic analysis to discover new biomarkers of overall survival and tumor progression in ovarian cancer patients. More specifically, we determined whether nuclear-encoded mitochondrial genes related to mitochondrial biogenesis and function are effective in predicting clinical outcome in ovarian cancer. As a consequence, we are able to provide in silico validation of the prognostic value of these mitochondrial markers, in a well-defined population of ovarian cancer patients. Towards this end, we used a group of N=111 ovarian cancer patients (serous type; stage III), with optimal de-bulking...
September 15, 2017: Oncotarget
https://www.readbyqxmd.com/read/28977941/ccne1-expression-in-high-grade-serous-carcinoma-does-not-correlate-with-chemoresistance
#10
Stav Sapoznik, Sarit Aviel-Ronen, Keren Bahar-Shany, Oranit Zadok, Keren Levanon
Delayed diagnosis of ovarian cancer, as well as high recurrence rates and lack of personalized therapy options, are among the causes for poor survival figures. Much effort is made towards developing new therapeutic possibilities, however predictive biomarkers are still unavailable. CCNE1 amplification, occurring in ∼20% of the high grade serous ovarian tumors, was previously proposed as a marker for platinum resistance and poor prognosis as well as for CDK2 inhibition. The current study aimed to examine the role of CCNE1 positive-immunostain as a predictor of first-line taxane-platinum chemoresistance...
September 22, 2017: Oncotarget
https://www.readbyqxmd.com/read/28976449/a-2-protein-signature-predicting-clinical-outcome-in-high-grade-serous-ovarian-cancer
#11
Chengjuan Jin, Yingfeng Xue, Yingwei Li, Hualei Bu, Hongfeng Yu, Tao Zhang, Zhiwei Zhang, Shi Yan, Nan Lu, Beihua Kong
OBJECTIVE: High-grade serous ovarian cancer (HGSOC) accounts for approximately 70% deaths in ovarian cancer. The overall survival (OS) of HGSOC is poor and still remains a clinical challenge. High-grade serous ovarian cancer can be divided into 4 molecular subtypes. The prognosis of different molecular subtypes is still unclear. We aimed to investigate the prognostic values of immunohistochemistry-based different molecular subtypes in patients with HGSOC. METHODS: We analyzed the protein expression of representative biomarkers (CXCL11, HMGA2, and MUC16) of 3 different molecular subtypes in 110 formalin-fixed, paraffin-embedded HGSOC by tissue microarrays...
October 3, 2017: International Journal of Gynecological Cancer
https://www.readbyqxmd.com/read/28971890/altered-mirna-profile-dependent-on-art-outcome-in-early-pregnancy-targets-wnt-pathway
#12
Alexander Freis, Andreas Keller, Nicole Ludwig, Eckart Meese, Julia Jauckus, Julia Rehnitz, Edison Capp, Thomas Strowitzki, Ariane Germeyer
Main goal of this study is to detect possible alterations in microRNA(miRNA)-expression and the pathway targeted in plasma at the time of embryo transfer and pregnancy testing dependent on the assisted reproductive treatment (ART) outcome after ovarian hyperstimulation for in vitro fertilization. Changes in miRNA-expression in plasma of women, who became pregnant (n=6) vs. women who failed implantation (n=6) following day 5 embryo transfer (ET), were investigated at day of ET and pregnancy testing (PT). Protein expression to validate the finding was performed with a sample size of n=20 (10 per group) using enzyme-linked immunosorbent assay...
September 29, 2017: Reproduction: the Official Journal of the Society for the Study of Fertility
https://www.readbyqxmd.com/read/28970963/ultrasensitive-tumour-penetrating-nanosensors-of-protease-activity
#13
Ester J Kwon, Jaideep S Dudani, Sangeeta N Bhatia
The ability to identify cancer lesions with endogenous biomarkers is currently limited to tumours ~1 cm in diameter. We recently reported an exogenously administered tumour-penetrating nanosensor that sheds, in response to tumour-specific proteases, peptide fragments that can then be detected in the urine. Here, we report the optimization, informed by a pharmacokinetic mathematical model, of the surface presentation of the peptide substrates to both enhance on-target protease cleavage and minimize off-target cleavage, and of the functionalization of the nanosensors with tumour-penetrating ligands that engage active trafficking pathways to increase activation in the tumour microenvironment...
2017: Nature biomedical engineering
https://www.readbyqxmd.com/read/28969705/report-on-the-first-slfn11-monothematic-workshop-from-function-to-role-as-a-biomarker-in-cancer
#14
Alberto Ballestrero, Davide Bedognetti, Domenico Ferraioli, Paola Franceschelli, Sana Intidhar Labidi-Galy, Elisabetta Leo, Junko Murai, Yves Pommier, Petros Tsantoulis, Valerio Gaetano Vellone, Gabriele Zoppoli
SLFN11 is a recently discovered protein with a putative DNA/RNA helicase function. First identified in association with the maturation of thymocytes, SLFN11 was later causally associated, by two independent groups, with the resistance to DNA damaging agents such as topoisomerase I and II inhibitors, platinum compounds, and other alkylators, making it an attractive molecule for biomarker development. Later, SLFN11 was linked to antiviral response in human cells and interferon production, establishing a potential bond between immunity and chemotherapy...
October 2, 2017: Journal of Translational Medicine
https://www.readbyqxmd.com/read/28969424/development-of-a-long-lived-luminescence-probe-for-visualizing-%C3%AE-galactosidase-in-ovarian-carcinoma-cells
#15
Wanhe Wang, Kasipandi Vellaisamy, Guodong Li, Chun Wu, Chung-Nga Ko, Chung-Hang Leung, Dik-Lung Ma
β-Galactosidase (β-gal) is an important biomarker for ovarian cancers. In this work, we designed and synthesized a novel iridium(III)-based probe 1 for discriminating ovarian carcinoma cell lines from normal cell lines. The probe could detect β-gal even in the presence of a highly autofluorescent background. The probe also showed a good linear response to β-gal between 0 and 30 U/mL, with a detection limit of 0.51 U/mL. Importantly, complex 1 could selectively "light up" ovarian carcinoma cells, while exhibiting negligible luminescence in normal cells...
October 3, 2017: Analytical Chemistry
https://www.readbyqxmd.com/read/28969062/identification-of-long-non-coding-rna-signature-for-paclitaxel-resistant-patients-with-advanced-ovarian-cancer
#16
Luqing Wang, Yanjun Hu, Xiaohong Xiang, Kai Qu, Yue Teng
Ovarian cancer is the most lethal gynecologic malignancy, characterized by late diagnosis, frequent relapse, and easy development of chemoresistance. Recent studies suggest that lncRNAs are involved in ovarian cancer onset and progression, as well as the resistance in paclitaxel-containing chemotherapy. However, the genome-wide expression pattern and associated functional implications of lncRNAs in paclitaxel-resistant ovarian cancer cells remain undetermined. In the present study, we identified a panel of lncRNAs aberrantly expressed in both paclitaxel resistant ovarian cancer tissues and cell lines, including XR_948297, XR_947831, XR_938728, XR_938392, NR_103801, NR_073113, and NR_036503...
September 8, 2017: Oncotarget
https://www.readbyqxmd.com/read/28966695/ipi59-an-actionable-biomarker-to-improve-treatment-response-in-serous-ovarian-carcinoma-patients
#17
J Choi, S Ye, K H Eng, K Korthauer, W H Bradley, J S Rader, C Kendziorski
Despite improvements in operative management and therapies, overall survival rates in advanced ovarian cancer have remained largely unchanged over the past three decades. Although it is possible to identify high-risk patients following surgery, the knowledge does not provide information about the genomic aberrations conferring risk, or the implications for treatment. To address these challenges, we developed an integrative pathway-index model and applied it to messenger RNA expression from 458 patients with serous ovarian carcinoma from the Cancer Genome Atlas project...
June 2017: Statistics in Biosciences
https://www.readbyqxmd.com/read/28965553/patient-tailored-ovarian-stimulation-for-in%C3%A2-vitro-fertilization
#18
REVIEW
Bart C J M Fauser
At present, much attention in medicine is being directed toward individualized or patient-tailored care with the use of novel tools such as biomarkers or genomics. Research tools different from randomized controlled trials, focusing on the heterogeneity of patients rather than the intervention per se, are required to develop this concept further. In infertility care, few examples of individualized approaches with the use of multivariate prediction models can be found, such as the prediction of spontaneous conception chances in infertile patients or regarding the medical treatment of anovulatory infertility...
October 2017: Fertility and Sterility
https://www.readbyqxmd.com/read/28960399/role-of-intracystic-cytokines-and-nitric-oxide-in-ovarian-neoplasms
#19
Agrimaldo Martins Filho, Millena Prata Jammal, Douglas Côbo Micheli, Beatriz Martins Tavares-Murta, Renata Margarida Etchebehere, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini
The development of new biomarkers for the diagnosis and prognosis of ovarian cancer may provide an opportunity for new therapies. In this study, we aimed to compare cytokines (interleukin [IL]-2, IL-5, IL-6, IL-8, IL-10, and tumor necrosis factor [TNF]-α) and nitric oxide (NO) metabolite levels in non-neoplastic tumors, benign primary ovarian tumors, and malignant primary ovarian neoplasms. The secondary aim was to relate cytokine and intracystic NO metabolite levels to clinical, laboratory, and pathologic characteristics for patients with primary ovarian malignancies...
September 28, 2017: Scandinavian Journal of Immunology
https://www.readbyqxmd.com/read/28955188/premenopausal-reproductive-health-modulates-future-cardiovascular-risk-comparative-evidence-from-monkeys-and-women%C3%A2-%C3%A2-%C3%A2
#20
REVIEW
Jay R Kaplan, Stephen B Manuck
Coronary heart disease (CHD) remains the major cause of mortality among postmenopausal women living in industrialized countries. Several lines of evidence suggest that ovarian hormones (especially estrogen) protect the coronary arteries of premenopausal women. However, it is also known that women commonly experience disruptions in cyclic hormonal function during their reproductive years. In this perspective, we hypothesize that if regular, cyclic ovarian function affords protection against CHD, ovulatory abnormalities in young women may conversely promote the development of atherosclerosis (the pathobiological process underlying CHD) in the years prior to menopause and thus substantially increase the risk of subsequent heart disease...
September 2017: Yale Journal of Biology and Medicine
keyword
keyword
120394
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"